Prestige Consumer Healthcare Inc.·4

Feb 13, 4:01 PM ET

Mekhail Adel 4

4 · Prestige Consumer Healthcare Inc. · Filed Feb 13, 2025

Insider Transaction Report

Form 4
Period: 2025-02-11
Mekhail Adel
EVP, Marketing & Sales
Transactions
  • Sale

    Common Stock, par value $0.01 per share

    2025-02-11$86.82/sh5,400$468,82818,365 total
  • Exercise/Conversion

    Employee Stock Options (rights to buy)

    2025-02-115,4000 total
    Exercise: $44.33Exp: 2031-05-03Common Stock (5,400 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.01 per share

    2025-02-11$54.47/sh+5,683$309,55324,048 total
  • Sale

    Common Stock, par value $0.01 per share

    2025-02-11$86.30/sh5,683$490,44318,365 total
  • Exercise/Conversion

    Employee Stock Options (rights to buy)

    2025-02-115,6832,842 total
    Exercise: $54.47Exp: 2032-05-02Common Stock (5,683 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.01 per share

    2025-02-11$44.33/sh+5,400$239,38223,765 total
Footnotes (4)
  • [F1]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $86.00 to $86.82.
  • [F2]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $86.00 to $86.30.
  • [F3]The options vested in three equal installments of 3,655 shares on May 4, 2021, May 4, 2022 and May 4, 2023.
  • [F4]The options vests in three equal installments of 2,841 shares each on May 2,2023 and 2,842 shares each on May 3, 2024 and May 3, 2025

Documents

1 file
  • 4
    tm256546-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT